FAES FARMA, S.A. (FAE.MC)
Makes medicines, animal nutrition products, and pharmaceutical ingredients for global markets.
4.61+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+6.8%
The outlook
FAES trades near the lower-middle of its 52-week range, with analyst consensus leaning toward Buy and an average price target roughly 16% above current levels. The stock shows mixed momentum against its moving averages, and carries a trailing P/E of 18.4 alongside a neutral overall score.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range38% of the way from its 52-week low to high
Price targetAvg target +16% vs current price
Analyst price target
~12-month · 4 analysts5.36average target+16.3% vs now
Now 4.61
Low 4.82High 6.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
5.44
52-wk low
4.10
50-day avg
4.55
200-day avg
4.77
Trailing P/E
18.4